Abstract
Atherosclerosis of the coronary arteries, accompanied by a narrowing of their lumen and the inability to provide adequate blood flow, is the main cause of ischemic heart disease. Significantly reducing the quality of life of patients, ischemic heart disease is dangerous for the development of life-threatening complications. It is known that coronary artery bypass grafting is still one of the main method of treatments from the point of increasing survival rates and avoidinig resergions for most patients, in particular, in patients with multivessel coronary disease. The main task of coronary artery bypass grafting is to create a roundabout path of blood flow and select a reliable conduit that can function for a long time, affecting the duration and quality of life of the patient. This clinical case provides an example of a successful surgical treatment of ischemic heart disease in a young male patient after phlebectomy. The patient underwent the coronary artery bypass grafting where two internal mammary arteries and a small saphenous vein were used as conduits. 5-year follow-up is provided.
References
- Michele M.G., Colivicchi F., Abrignani M.G., Ambrosetti M., Aspromonte N., Barile G. et al. Long-term Antiplatelet Therapy in patients with coronary artery disease ESC Scientific Document Group, Faculty for approval of the Consensus Document. Eur. Heart J. 2018; 20 (Suppl F): F1–F74. DOI: 10.1093/eurheartj/suy019
- Saewae U., Chetty G., Sarkar P. The short saphenous vein: a viable alternative conduit for coronary artery bypass grafts harvested using a novel technical approach. J. Surg. Tech. Case Rep. 2012; 4 (1): 61–3. DOI: 10.4103/ 2006-8808.100359
- Brandt P.C., Greene C.G., Maggart M.L., Hall W.C., Harville L.E., Pollard Th.R., Stouffer C.W. Endoscopic vein harvest of the lesser saphenous vein in the supine position: a unique approach to an old problem. Interact. Cardiovasc. Thorac. Surg. 2013; 1 (1–4). DOI: 10.1093/ icvts/ivs414
- Otsuka F., Yahagi K., Sakakura K., Virmani R. Why is the mammary artery so special and what protects it from atherosclerosis? Ann. Cardiothorac. Surg. 2013; 2 (4): 519–26.
- Umakanthan J., Jeyakumar P., Umakanthan B., Jeyakumar N., Senthilkumar N., Saraswathy M.R. et al. Barriers to the universal adoption of bilateral internal mammary artery grafting. Int. J. Surg. 2015; 16 (Pt B): 179–82.
- Benedetto U., Altman D.G., Gerry S., Gray A., Lees B., Pawlaczyk R. et al. Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: insights from the Arterial Revascularization Trial. J. Thorac. Cardiovasc. Surg. 2016; 152 (1): 270–6.
- Zhu Y.Y., Seco M., Harris S.R., Wilson M., Bannon P.G., Michael P. Vallely M.P. Bilateral versus single internal mammary artery use in coronary artery bypass grafting: a propensity matched analysis. Heart Lung Circ. 2019; 28 (5): 807–13. DOI: 10.1016/j.hlc.2018.03.022
- Taggart D.P., Benedetto U., Gerry S., Altman D.G., Gray A.G., Gaudino M. et al. Bilateral versus single internal-thoracic-artery grafts at 10 years. N. Engl. J. Med. 2019; 380: 437–46. DOI: 10.1056/NEJMoa 1808783 9. Lazar H.L. The arterial revascularization trial: it is what it is. J. Am. Heart Assoc. 2019; 8: e015046. DOI: 10.1161/ JAHA.119.015046
About the authors
- Leo A. Bockeria, Dr. Med. Sci., Professor, Academican of RAS; ORCID
- Lasha D. Shengelia, Cand. Med. Sci., Cardiovascular Surgeon, Research Associate; ORCID
- Sergey A. Donakanyan, Dr. Med. Sci., Professor, Head of Department; ORCID
- Pavel P. Rubtsov, Cand. Med. Sci., Cardiovascular Surgeon, Senior Research Associate
- Maria O. Konshina, Cardiology Resident
